TY - JOUR T1 - GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates. JF - N Engl J Med Y1 - 2017 A1 - Roca-Ayats, Neus A1 - Balcells, Susana A1 - Garcia-Giralt, Natàlia A1 - Falcó-Mascaró, Maite A1 - Martínez-Gil, Núria A1 - Abril, Josep F A1 - Urreizti, Roser A1 - Dopazo, Joaquin A1 - Quesada-Gómez, José M A1 - Nogués, Xavier A1 - Mellibovsky, Leonardo A1 - Prieto-Alhambra, Daniel A1 - Dunford, James E A1 - Javaid, Muhammad K A1 - Russell, R Graham A1 - Grinberg, Daniel A1 - Díez-Pérez, Adolfo KW - Aged KW - Amino Acid Sequence KW - Bone Density Conservation Agents KW - Dimethylallyltranstransferase KW - Diphosphonates KW - Exome KW - Farnesyltranstransferase KW - Female KW - Femoral Fractures KW - Geranyltranstransferase KW - Humans KW - Middle Aged KW - mutation VL - 376 UR - http://www.nejm.org/doi/full/10.1056/NEJMc1612804 IS - 18 U1 - https://www.ncbi.nlm.nih.gov/pubmed/28467865?dopt=Abstract ER - TY - JOUR T1 - Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes. JF - Am J Med Genet A Y1 - 2016 A1 - Urreizti, Roser A1 - Roca-Ayats, Neus A1 - Trepat, Judith A1 - Garcia-Garcia, Francisco A1 - Alemán, Alejandro A1 - Orteschi, Daniela A1 - Marangi, Giuseppe A1 - Neri, Giovanni A1 - Opitz, John M A1 - Dopazo, Joaquin A1 - Cormand, Bru A1 - Vilageliu, Lluïsa A1 - Balcells, Susana A1 - Grinberg, Daniel KW - Adolescent KW - Antigens, CD KW - Child KW - Child, Preschool KW - Craniosynostoses KW - Exome KW - Female KW - High-Throughput Nucleotide Sequencing KW - Humans KW - Infant KW - Intellectual Disability KW - Male KW - mutation KW - Pedigree KW - Phenotype KW - Prognosis KW - Repressor Proteins AB -

Opitz C trigonocephaly (or Opitz C syndrome, OTCS) and Bohring-Opitz syndrome (BOS or C-like syndrome) are two rare genetic disorders with phenotypic overlap. The genetic causes of these diseases are not understood. However, two genes have been associated with OTCS or BOS with dominantly inherited de novo mutations. Whereas CD96 has been related to OTCS (one case) and to BOS (one case), ASXL1 has been related to BOS only (several cases). In this study we analyze CD96 and ASXL1 in a group of 11 affected individuals, including 2 sibs, 10 of them were diagnosed with OTCS, and one had a BOS phenotype. Exome sequences were available on six patients with OTCS and three parent pairs. Thus, we could analyze the CD96 and ASXL1 sequences in these patients bioinformatically. Sanger sequencing of all exons of CD96 and ASXL1 was carried out in the remaining patients. Detailed scrutiny of the sequences and assessment of variants allowed us to exclude putative pathogenic and private mutations in all but one of the patients. In this patient (with BOS) we identified a de novo mutation in ASXL1 (c.2100dupT). By nature and location within the gene, this mutation resembles those previously described in other BOS patients and we conclude that it may be responsible for the condition. Our results indicate that in 10 of 11, the disease (OTCS or BOS) cannot be explained by small changes in CD96 or ASXL1. However, the cohort is too small to make generalizations about the genetic etiology of these diseases.

VL - 170A IS - 1 U1 - https://www.ncbi.nlm.nih.gov/pubmed/26768331?dopt=Abstract ER -